Introduction Chronic obstructive pulmonary disease (COPD) is one of the main causes of
death and disability worldwide. Many treatment options are now available, but criteria for …

Pharmacological treatment for chronic obstructive pulmonary disease (COPD) aims to
alleviate symptoms and reduce the future risk of events such as exacerbations, disease …

Objectives To evaluate the degree to which evidence from large clinical trials can be applied
to patients treated in a local hospital cohort of COPD outpatients. Methods The authors …

Chronic obstructive pulmonary disease (COPD) is one of the most common diseases
worldwide. Although different guidelines regarding therapeutic algorithms exist, the most …

363 versions of the guidelines. Observed adherence to treatment differed from expected in
all stages and groups, whereas the differences between groups were marginally statistically …

In 1995, the European Respiratory Society published a European Consensus Statement on
the optimal assessment and management of COPD. In the document, several important …

Abstract Background Chronic Obstructive Pulmonary Disease (COPD) is a disease state
characterized by airflow limitation that is not fully reversible and usually progressive. Current …

In 2014, Lung Foundation Australia (LFA) first published the 'COPD-X Concise Guide for
Primary Care'with the aim of distilling the more detailed 'The COPD-X plan: Australian and …

Abstract The Spanish COPD Guidelines (GesEPOC) were first published in 2012, and since
then have undergone a series of updates incorporating new evidence on the diagnosis and …

The implementation of potential new step‐up or step‐down treatment recommendations in
response to current guidelines is one of the main challenges currently faced in actual daily …